161 related articles for article (PubMed ID: 20358302)
21. Prevention of venous thromboembolism in critically ill surgery patients: a cross-sectional study.
Cook D; Laporta D; Skrobik Y; Peters S; Sharpe M; Murphy P; Chin D; Crowther M;
J Crit Care; 2001 Dec; 16(4):161-6. PubMed ID: 11815901
[TBL] [Abstract][Full Text] [Related]
22. Thromboembolic disease in surgery for malignancy-rationale for prolonged thromboprophylaxis.
Khushal A; Quinlan D; Alikhan R; Gardner J; Bailey C; Cohen A
Semin Thromb Hemost; 2002 Dec; 28(6):569-76. PubMed ID: 12536350
[TBL] [Abstract][Full Text] [Related]
23. Low-molecular-weight heparins in the treatment of cancer-associated thrombosis: a new standard of care?
Burris HA
Semin Oncol; 2006 Apr; 33(2 Suppl 4):S3-16; quiz S41-2. PubMed ID: 16638456
[TBL] [Abstract][Full Text] [Related]
24. Postoperative bleeding complications after gastric cancer surgery in patients receiving anticoagulation and/or antiplatelet agents.
Mita K; Ito H; Murabayashi R; Sueyoshi K; Asakawa H; Nabetani M; Kamasako A; Koizumi K; Hayashi T
Ann Surg Oncol; 2012 Nov; 19(12):3745-52. PubMed ID: 22805868
[TBL] [Abstract][Full Text] [Related]
25. Treatment of venous thromboembolism in cancer patients.
Petralia GA; Kakkar AK
Semin Thromb Hemost; 2007 Oct; 33(7):707-11. PubMed ID: 18000799
[TBL] [Abstract][Full Text] [Related]
26. Antithrombotic therapy and survival in cancer patients.
Kakkar AK
Best Pract Res Clin Haematol; 2009 Mar; 22(1):147-51. PubMed ID: 19285281
[TBL] [Abstract][Full Text] [Related]
27. [Prevention of thromboembolism with low-molecular-weight heparin in ambulatory surgery and unoperated surgical and orthopedic patients].
Harenberg J; Piazolo L; Misselwitz F
Zentralbl Chir; 1998; 123(11):1284-7. PubMed ID: 9880848
[TBL] [Abstract][Full Text] [Related]
28. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery.
Mismetti P; Laporte S; Darmon JY; Buchmüller A; Decousus H
Br J Surg; 2001 Jul; 88(7):913-30. PubMed ID: 11442521
[TBL] [Abstract][Full Text] [Related]
29. Low molecular weight heparin: a critical analysis of clinical trials.
Green D; Hirsh J; Heit J; Prins M; Davidson B; Lensing AW
Pharmacol Rev; 1994 Mar; 46(1):89-109. PubMed ID: 8190751
[TBL] [Abstract][Full Text] [Related]
30. Prevention of deep vein thrombosis in orthopedic surgery.
Eichinger S; Kyrle PA
Eur J Med Res; 2004 Mar; 9(3):112-8. PubMed ID: 15096320
[TBL] [Abstract][Full Text] [Related]
31. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
32. Should patients be informed about the risk of heparin-induced thrombocytopenia before prolonged low-molecular-weight heparin thromboprophylaxis post-trauma/orthopedic surgery?
Lubenow N; Hinz P; Ekkernkamp A; Greinacher A
Eur J Haematol; 2007 Sep; 79(3):187-90. PubMed ID: 17655709
[TBL] [Abstract][Full Text] [Related]
33. Risk of venous thromboembolism in patients undergoing cancer surgery and options for thromboprophylaxis.
Bergqvist D
J Surg Oncol; 2007 Feb; 95(2):167-74. PubMed ID: 17262765
[TBL] [Abstract][Full Text] [Related]
34. Thromboembolism prophylaxis and incidence of thromboembolic complications after laparoscopic surgery.
Catheline JM; Capelluto E; Gaillard JL; Turner R; Champault G
Int J Surg Investig; 2000; 2(1):41-7. PubMed ID: 12774337
[TBL] [Abstract][Full Text] [Related]
35. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.
Nishioka J; Goodin S
J Oncol Pharm Pract; 2007 Jun; 13(2):85-97. PubMed ID: 17873108
[TBL] [Abstract][Full Text] [Related]
36. Can we use a low molecular weight heparin after mechanical prosthetic heart valve surgery?
Meurin P; Tabet JY
Heart; 2008 Feb; 94(2):131-2. PubMed ID: 18195116
[No Abstract] [Full Text] [Related]
37. Managing the risk of venous thromboembolism in orthopedics: concluding remarks.
Haas S
Orthopedics; 1997 Feb; 20 Suppl():26-7. PubMed ID: 9048405
[No Abstract] [Full Text] [Related]
38. Randomized clinical trial of low molecular weight heparin with thigh-length or knee-length antiembolism stockings for patients undergoing surgery.
Howard A; Zaccagnini D; Ellis M; Williams A; Davies AH; Greenhalgh RM
Br J Surg; 2004 Jul; 91(7):842-7. PubMed ID: 15227689
[TBL] [Abstract][Full Text] [Related]
39. Preventing thromboembolic complications in cancer patients after surgery: a role for prolonged thromboprophylaxis.
Rasmussen MS
Cancer Treat Rev; 2002 Jun; 28(3):141-4. PubMed ID: 12234565
[TBL] [Abstract][Full Text] [Related]
40. Randomized trial of the effect of the low molecular weight heparin nadroparin on survival in patients with cancer.
van Doormaal FF; Di Nisio M; Otten HM; Richel DJ; Prins M; Buller HR
J Clin Oncol; 2011 May; 29(15):2071-6. PubMed ID: 21502549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
